News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

CSL plots millions of doses of COVID-19 vaccine shots, including AstraZeneca's, for Aussie government

Looking to secure enough doses of a COVID-19 vaccine frontrunner for its residents, the Australian governmentsigned an expansive supply deal with British drugmaker AstraZeneca last month. The Aussies
2020/9/8
Biocon, Mylan's Lantus copy; Samsung rides COVID-19 demand; Adlai Nortye's C round

Mylan and Biocon will launch Semglee, their biosimilar of Sanofi's Lantus, at a discount. Samsung Biologics' $2 billion "Super Plant" expansion is the result of increased demand partly due to COVID-1
2020/9/7
Amgen wriggles out of state bill on rat poisons, says it prefers its rodent-killing methods

With a bill passed this week, California legislators and environmentalists cast a spotlight on the use of industrial rodent poisons that are killing off native wildlife. But local drugmaker Amgen wan
2020/9/7
Biotech CEOs pen standards for coronavirus trials, data disclosures amid FDA reputation crisis

Amiddoubts about the FDA’sdecision-makingprocessduring the pandemic,biotechCEOson the front lines of research arelaying outtheir approachand asking“all parties”involved in the process to adhere to hi
2020/9/4
Catalent pumps $50M into Indiana fill-finish capacity with COVID-19 vaccine contracts in hand

With a suite of drugmakers looking for manufacturing partners in the hunt for a COVID-19 vaccine, major contract manufacturers are stepping in to help handle the load. One of those, New Jersey's Cata
2020/9/4
Amping up its sustainability goals, Novartis targets carbon neutrality across supply chain by 2030

In the past year or so, Novartis has focused on better governance by tightening its ethics standards. Now the Swiss pharma is also working to improveits corporate image from an environmental perspect
2020/9/3
Trump's touting a drug pricing meeting with execs, but PhRMA's 'not aware' of it

With two months until the election, President Donald Trump has made numerouspledges about drug pricing over the past few weeks. But his latestclaim ofameeting set between the White House and drug exe
2020/9/3
Rebuking FDA, NIH experts say 'no data' support plasma as a COVID-19 treatment

A deadly pandemic isn't thetime for leading U.S. health agencies to disagree on data and treatment benefits, but that's the situation playing out as new COVID-19treatment guidelinesfrom the National
2020/9/1
U.S. Army taps Florida CDMO Ology with $106M work order for COVID-19 shots, therapeutics

With a suite of COVID-19 vaccines and therapeutics ontheir way to market, the U.S. government has been working to secure enough manufacturing capacity to meet demand. Now, the Army will pay big money
2020/8/28
Regeneron plots 400 hires to handle increased workload amid COVID-19 cocktail production push

Regeneron and Swiss drugmaker Roche made waves earlier this month with a gargantuan manufacturing pact to triple production of a hopeful COVID-19 antibody cocktail. But those big plans put a crunch o
2020/8/28

Excipients